Jump to navigation
UArizona researchers have developed a new therapy for Alzheimer’s disease designed to restore cognitive function in early-stage patients. The therapy has been licensed to startup NeuTherapeutics Inc.
NASA and UArizona scientists were able to significantly reduce uncertainties about asteroid Bennu's orbit and determine the likelihood of the asteroid impacting Earth between now and the year 2300.
Data shows that 67% of people with mild or moderate COVID-19 infection develop long COVID, with symptoms that last more than 30 days after a positive test.
Scientists have long debated what is under the surface of Mars' south pole. A new study points to clays being more likely than a subsurface lake.
UArizona's CyVerse will take part in a $20 million institute that aims to transform agriculture through artificial intelligence.
New UArizona-led research identifies climate change challenges faced by U.S. Department of Defense facilities, and solutions that might serve as a model for other large organizations.
A less invasive optogenetic device, which shines light at specific neurons in the brain, takes researchers a step closer to new treatments for chronic pain, depression, epilepsy and more.
The university achieved a record 124 license agreements, launched 17 new companies, and grew the number of inventions disclosed and patents filed.
A study that started by analyzing COVID-19 immunity and vaccine effectiveness in frontline workers is broadening to include children, thanks to a $15 million grant renewal from the Centers for Disease Control and Prevention.
UArizona is providing the software hub for the NEID spectrometer on Kitt Peak as the instrument begins its mission to discover Earth-like planets elsewhere in the Milky Way.